{"id":"hl151","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Limited public information is available regarding HL151's specific mechanism of action. As a phase 3 candidate from Hanlim Pharm, it has progressed through early clinical evaluation, but detailed mechanistic data has not been widely published in accessible pharmaceutical databases or literature.","oneSentence":"HL151 is an investigational therapeutic agent in phase 3 development by Hanlim Pharm, with mechanism details not publicly disclosed.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:44:48.009Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT03655210","phase":"PHASE3","title":"To Evaluate the Efficacy and Safety of HL151 Versus Placebo in Perennial Allergic Rhinitis Patients","status":"COMPLETED","sponsor":"Hanlim Pharm. Co., Ltd.","startDate":"2017-02-07","conditions":"Perennial Allergic Rhinitis","enrollment":272},{"nctId":"NCT03317301","phase":"PHASE3","title":"Evaluate the Efficacy and Safety of HL151 Versus Talion Tab. in Pruritus Cutaneus","status":"COMPLETED","sponsor":"Hanlim Pharm. Co., Ltd.","startDate":"2017-05-17","conditions":"Pruritus","enrollment":189},{"nctId":"NCT02686294","phase":"PHASE1","title":"Repeated Dosing Clinical Trial of HL151","status":"COMPLETED","sponsor":"Hanlim Pharm. Co., Ltd.","startDate":"2016-02-16","conditions":"Rhinitis, Allergic, Perennial","enrollment":30},{"nctId":"NCT02682745","phase":"PHASE1","title":"Single Dosing Clinical Trial of HL151","status":"COMPLETED","sponsor":"Hanlim Pharm. Co., Ltd.","startDate":"2016-01-15","conditions":"Rhinitis, Allergic, Perennial","enrollment":30}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"HL151","genericName":"HL151","companyName":"Hanlim Pharm. Co., Ltd.","companyId":"hanlim-pharm-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":4,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}